Pharmacological approaches to the treatment of tinnitus

被引：56

作者：

Elgoyhen, Ana B. ^{[1
,2
]}

Langguth, Berthold ^{[3
]}

机构：

[1] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, RA-1428 Buenos Aires, DF, Argentina

[2] Univ Buenos Aires, Fac Med, Dept Farmacol, RA-1121 Buenos Aires, DF, Argentina

[3] Univ Regensburg, Interdisciplinary Tinnitus Clin, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany

来源：

DRUG DISCOVERY TODAY | 2010年 / 15卷 / 7-8期

关键词：

INDUCED HEARING-LOSS; DOUBLE-BLIND; PSYCHIATRIC-DISORDERS; LATERALIZED TINNITUS; RANDOMIZED TRIAL; NOISE; GABAPENTIN; DRUGS; CARBAMAZEPINE; MISOPROSTOL;

D O I：

10.1016/j.drudis.2009.11.003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Tinnitus is the conscious perception of a phantom sound in the absence of an external source. For 1 in 100 of the general population, the condition severely affects quality of life. In spite of the fact that the market for a drug indicated for tinnitus relief is huge, there are still no FDA-approved drugs, and the quest for a tinnitus-targeted compound faces important challenges. A wide variety of drugs have been used off-label to treat tinnitus sufferers, with limited but significant effects in subsets of patients. If the compounds being developed at present by the pharmaceutical industry finally reach the market, they will establish a turning point in the treatment of this pathology.

引用

页码：300 / 305

页数：6

共 69 条

[1] Tinnitus in the older adult - Epidemiology, pathophysiology and treatment options [J].